Home
Finance
Companies
Industry
Market

XBIO

why Xenetic Biosciences Inc [XBIO] is a Good Choice for Investors After New Price Target of $40.00

October 9, 2025

Caleb Clifford

Xenetic Biosciences Inc [NASDAQ: XBIO] gained 141.49% or 6.07 points to close at $10.36 with a heavy trading volume of ...

most recent

Industry

Costar Group, Inc [CSGP] fell -5.33% so far this year. What now?

Finance

Market cap of Palisade Bio Inc [PALI] reaches 281.97M – now what?

Companies

B. Riley Securities slashes price target on PDS Biotechnology Corporation [PDSB] – find out why.

Market

Cantor Fitzgerald lifts SELLAS Life Sciences Group Inc [SLS] price estimate. Who else is bullish?

Industry

Flex Ltd [FLEX] stock Resumed by Stifel analyst, price target now $52

Finance

Array Technologies Inc [ARRY] is 38.51% higher this YTD. Is it still time to buy?

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled